Blog

On October 30, 2025, Liu et al. from Guangdong Provincial Key Laboratory of Marine Biotechnology published an article in the journal Marine Drugs titled "Novel Sulfated Oligosaccharide DP9 from Marine Algae, Gracilaria lemaneiformis: A Potent Galectin-3 Inhibitor for Pancreatic Cancer Therapy". The paper investigates the discovery and structural characterization of a novel Sulfated Oligosaccharide, designated […]

On November 3, 2025, the research team of Yu, Jin, and colleagues, experts in marine natural product chemistry, published an article in the journal Marine Drugs titled " Structural Comparison and Therapeutic Effects on Ulcerative Colitis of Fucoidan and Its Derivative from Saccharina japonica". The paper investigates the structural comparison and therapeutic application of a […]

On November 5, 2025, a collaborative team of researchers (Mosievich, Balabushevich, et al.) published an article in the journal Marine Drugs titled "Vaterite/Fucoidan Hybrid Microparticles: Fabrication, Loading of Lactoferrin, Structural Characteristics and Functional Properties." The paper details the fabrication and comprehensive Characterization of stable vaterite/fucoidan hybrid microparticles designed to encapsulate the therapeutic protein lactoferrin. The […]

On November 13, 2025, researchers led by I. Metón and colleagues published an article in the journal Marine Drugs titled "Chitosan-Mediated Expression of Caenorhabditis elegans fat-1 and fat-2 in Sparus aurata: Short-Term Effects on the Hepatic Fatty Acid Profile, Intermediary Metabolism, and Proinflammatory Factors." The paper investigates the use of chitosan—a primary Marine-derived Polysaccharide—as a […]

On August 28, 2025, Anisimova et al. published an article in Marine Drugs, titled "Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis". The research validates a novel method for sustained hematopoietic support. The central innovation involves incorporating Fucosylated Chondroitin Sulfate (FCS), a potent glycosaminoglycan derived from marine […]

On August 25, 2025, Gu et al. from Ocean University of China published their latest research results in Marine Drugs, entitled "New Strategy for the Degradation of High-Concentration Sodium Alginate with Recombinant Enzyme 102C300C-Vgb and the Beneficial Effects of Its Degradation Products on the Gut Health of Stichopus japonicus". They have pioneered a novel biotechnological […]

On August 29, 2025, Kaczmarek et al. from the Łukasiewicz Research Network—Lodz Institute of Technology and the University of Lodz (Poland) published their latest research findings in Marine Drugs, titled "Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite". In the field of biomedical materials, the development of blood-contacting devices (e.g., […]

On September 19, 2025, Xu et al. from the Key Laboratory of Marine Drugs of the Ministry of Education, and related institutions published an article in the journal Marine Drugs titled "Novel pH-Responsive PSS-Loaded Chitosan Matrix Nanoparticles Ameliorate Pressure Overload-Induced Cardiac Hypertrophy." This study focuses on addressing the therapeutic challenge of pressure overload-induced cardiac hypertrophy. […]